Breathe Well Live Well
Economic Times |
Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under … |
View full post on asthma – Google News
Economic Times |
India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will … Cipla targets US with asthma, HIV drugs |
View full post on asthma – Google News
Economic Times |
India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will … Cipla launches Serroflo in Germany and Sweden with affordable high quality … |
View full post on asthma – Google News
|
FDA approves GSK's Arnuity Ellipta to treat asthma in US
Pharmaceutical Business Review The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) fluticasone furoate inhalation powder, to be sold as Arnuity Ellipta, as a daily-once corticosteroid for treatment of asthma in patients aged above twelve years in the US. |
View full post on asthma – Google News
Bidness Etc |
GSK's Asthma Treatment Gets FDA Approval
Bidness Etc Yesterday, GlaxoSmithKline plc (GSK) announced that the Food and Drug Administration (FDA) has given marketing approval for its drug Arnuity Ellipta, developed as an asthma treatment in patients aged 12 and older. Asthma is a lingering lung disease … FDA OKs New Maintenance Asthma Treatment Arnuity Ellipta FDA approves GSK asthma medicine FDA approves GSK's Arnuity Ellipta for treating asthma |
View full post on asthma – Google News
Yahoo!7 News |
FDA issues generic guidance on GSK's top-selling asthma drug, Advair
Philly.com (blog) PhillyPharma. FDA issues generic guidance on GSK's top-selling asthma drug, Advair. GlaxoSmithKline's top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue. Generic competition got a bit closer … GlaxoSmithKline Shares Fall After Advair Setback Glaxo Declines as FDA Clears Path for Advair Rivals New FDA guidance threatens GlaxoSmithKline's Advair |
View full post on asthma – Google News